Aurora Spine Corporation Schedules Release of Third Quarter

CARLSBAD, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and producer of progressive medical units that enhance spinal surgical procedure outcomes, right this moment introduced it is going to subject its monetary outcomes press launch for the third quarter ended September 30, 2022, on Monday, November 21, 2022. Management will host a convention name that day at 11:00 a.m. Eastern Time to debate the outcomes.

Third Quarter 2022 Conference Call Details

Date and Time: Monday, November 21, 2022, at 11:00 a.m. ET / 8:00 a.m. PT

Call-in Information: Interested events can entry the convention name by dialing (844) 861-5497 or (412) 317-5794.

Webcast: Interested events can entry the convention name by way of a reside webcast, which is offered by way of the next hyperlink: https://app.webinar.net/Rx9E6Lbwn4k or within the Investor Relations part of the Company’s web site at https://www.aurora-spine.com/investors-v02.

Replay: A teleconference replay of the decision can be accessible till November 28, 2022, at (877) 344-7529 or (412) 317-0088, replay entry code 5080066. Additionally, a replay of the webcast can be accessible within the Investor Relations part of the Company’s web site at https://www.aurora-spine.com/investors-v02 or at https://app.webinar.net/Rx9E6Lbwn4k for 90 days.

About Aurora Spine

Aurora Spine is concentrated on bringing new options to the spinal implant market by way of a collection of progressive, minimally invasive, regenerative spinal implant applied sciences. Additional data will be accessed at www.aurora-spine.com or www.aurorapaincare.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that time period is outlined within the insurance policies of the TSX Venture Exchange) accepts accountability for the adequacy or accuracy of this launch.

Forward-Looking Statements

This information launch comprises forward-looking data that entails substantial identified and unknown dangers and uncertainties, most of that are past the management of Aurora Spine, together with, with out limitation, these listed beneath “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information” in Aurora Spine’s closing prospectus (collectively, “forward-looking information”). Forward-looking data on this information launch consists of data regarding the proposed use and success of the corporate’s merchandise in surgical procedures. Aurora Spine cautions traders of Aurora Spine’s securities about necessary elements that would trigger Aurora Spine’s precise outcomes to vary materially from these projected in any forward-looking statements included on this information launch. Any statements that specific, or contain discussions as to, expectations, beliefs, plans, targets, assumptions or future occasions or efficiency will not be historic information and could also be forward-looking and will contain estimates, assumptions and uncertainties which might trigger precise outcomes or outcomes to vary unilaterally from these expressed in such forward-looking statements. No assurance will be provided that the expectations set out herein will show to be right and, accordingly, potential traders mustn’t place undue reliance on these ahead–wanting statements. These statements communicate solely as of the date of this press launch and Aurora Spine doesn’t assume any obligation to replace or revise them to mirror new occasions or circumstances.

Contact:

Aurora Spine Corporation

Trent Northcutt

President and Chief Executive Officer

(760) 424-2004

Chad Clouse

Chief Financial Officer

(760) 424-2004

www.aurora-spine.com

Adam Lowensteiner

LYTHAM PARTNERS, LLC

Phoenix | New York

Telephone: 646-829-9700

[email protected]